OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.69+0.07 (+4.32%)
Close on Nov 18, 2026Market cap $1.26BP/E –Yield –
OPKO Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
OPKO Health's operating income for the twelve months ending Jun 30, 2026 was -$48.25M. For fiscal 2025 it was -$117.41M. The highest annual figure on record is $57.71M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$117.41M | – |
| FY2024 | Dec 31, 2024 | -$152.07M | – |
| FY2023 | Dec 31, 2023 | -$157.02M | – |
| FY2022 | Dec 31, 2022 | -$226.25M | -1306.7% |
| FY2021 | Dec 31, 2021 | $18.75M | -67.5% |
| FY2020 | Dec 31, 2020 | $57.71M | – |
| FY2019 | Dec 31, 2019 | -$274.05M | – |
| FY2018 | Dec 31, 2018 | -$171.20M | – |
| FY2017 | Dec 31, 2017 | -$276.44M | – |
| FY2016 | Dec 31, 2016 | -$96.55M | – |
| FY2015 | Dec 31, 2015 | -$98.48M | – |
| FY2014 | Dec 31, 2014 | -$145.82M | – |
| FY2013 | Dec 31, 2013 | -$79.63M | – |
| FY2012 | Dec 31, 2012 | -$37.27M | – |
| FY2011 | Dec 31, 2011 | -$23.19M | – |
| FY2010 | Dec 31, 2010 | -$11.14M | – |
| FY2009 | Dec 31, 2009 | -$22.15M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.97M | – |
| Q1 FY2026 | Mar 31, 2026 | -$51.02M | – |
| Q4 FY2025 | Dec 31, 2025 | -$38.32M | – |
| Q3 FY2025 | Sep 30, 2025 | $48.06M | – |
| Q2 FY2025 | Jun 30, 2025 | -$59.98M | – |
| Q1 FY2025 | Mar 31, 2025 | -$67.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$33.14M | – |
| Q3 FY2024 | Sep 30, 2024 | -$67.17M | – |
| Q2 FY2024 | Jun 30, 2024 | -$61.67M | -977.9% |
| Q1 FY2024 | Mar 31, 2024 | -$71.47M | – |
| Q4 FY2023 | Dec 31, 2023 | -$69.05M | – |
| Q3 FY2023 | Sep 30, 2023 | -$64.41M | – |
| Q2 FY2023 | Jun 30, 2023 | $7.03M | – |
| Q1 FY2023 | Mar 31, 2023 | -$30.59M | – |
| Q4 FY2022 | Dec 31, 2022 | -$55.27M | – |
| Q3 FY2022 | Sep 30, 2022 | -$87.82M | -332.2% |
| Q2 FY2022 | Jun 30, 2022 | -$10.74M | -292.8% |
| Q1 FY2022 | Mar 31, 2022 | -$72.42M | -288.4% |
| Q4 FY2021 | Dec 31, 2021 | -$63.08M | -227.8% |
| Q3 FY2021 | Sep 30, 2021 | $37.83M | +72.4% |
| Q2 FY2021 | Jun 30, 2021 | $5.57M | -79.5% |
| Q1 FY2021 | Mar 31, 2021 | $38.44M | – |
| Q4 FY2020 | Dec 31, 2020 | $49.36M | – |
| Q3 FY2020 | Sep 30, 2020 | $21.94M | – |
| Q2 FY2020 | Jun 30, 2020 | $27.18M | – |
| Q1 FY2020 | Mar 31, 2020 | -$40.76M | – |
| Q4 FY2019 | Dec 31, 2019 | -$112.46M | – |
| Q3 FY2019 | Sep 30, 2019 | -$39.01M | – |
| Q2 FY2019 | Jun 30, 2019 | -$47.26M | – |
| Q1 FY2019 | Mar 31, 2019 | -$75.32M | – |
| Q4 FY2018 | Dec 31, 2018 | -$90.01M | – |
| Q3 FY2018 | Sep 30, 2018 | -$33.46M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.11M | – |
| Q1 FY2018 | Mar 31, 2018 | -$42.61M | – |
| Q4 FY2017 | Dec 31, 2017 | -$157.63M | – |
| Q3 FY2017 | Sep 30, 2017 | -$47.77M | – |
| Q2 FY2017 | Jun 30, 2017 | -$25.83M | – |
| Q1 FY2017 | Mar 31, 2017 | -$45.22M | – |
| Q4 FY2016 | Dec 31, 2016 | -$73.68M | – |
| Q3 FY2016 | Sep 30, 2016 | -$23.62M | – |
See a number that looks wrong?